Tag Archives: SCAI

Top 10 Value Stocks To Invest In 2018

Warren Buffett’s Berkshire Hathaway Inc. was a big winner from the recent tax overhaul.

Book value, a metric he’s called a “crude, but useful” way to track the conglomerate’s worth, climbed 13 percent to $211,750 per Class A share at the end of 2017 compared to three months earlier, the company said Saturday in a statement. Analysts at Barclays Plc last month predicted that the measure of assets minus liabilities would rise as Berkshire lowered its tax liability on some appreciated investments. Buffett got a $29 billion boost to net earnings in the fourth quarter from the tax code changes.

Buffett had a mixed reaction to the tax overhaul passed by Congress last year. In January, he praised how the changes mean business owners will get a bigger share of profits and said he would have voted for it as a representative of Berkshire’s investors. Still, when asked if he would have encouraged legislators to support or fight it, Buffett said he would have gone with a different bill. The billionaire investor has long advocated for higher taxes on the wealthy, while the new law reduced the top income-tax rate.

Top 10 Value Stocks To Invest In 2018: Viacom Inc.(VIA)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    The Pillsbury Doughboy is the mascot of the Pillsbury Company, which is owned by General Mills (NYSE: GIS) and J.M. Smucker (NYSE: SJM). The Doughboy was created by Pillsburys advertising agency almost 50 years ago. Pikachu are characters owned by The Pokemon Company International and appear in card games, video games, TV shows, movies and comic books. Founded in 1998, the Japanese company has achieved total games sales of almost 280 million. SpongeBob SquarePants was created for Nickelodeon, which is owned by Viacom (NASDAQ: VIA). The show premiered in 1999 and has spawned movies, video games and theme park rides. Ronald McDonald is a c

  • [By Keith Noonan]

    While 2016 played host to a range of films that underperformed, the biggest flops belonged to Disney (NYSE:DIS), Viacom (NASDAQ:VIA) (NASDAQ:VIAB) and Lions Gate Entertainment (NYSE:LGF.A). Click through the presentation below to get the details on the year’s five biggest film flops and to learn what last year’s movie misfires mean for the companies involved.

Top 10 Value Stocks To Invest In 2018: Approach Resources Inc.(AREX)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, energy shares fell 0.83 percent. Meanwhile, top losers in the sector included Teekay Offshore Partners L.P. (NYSE: TOO), down 10 percent, and Approach Resources Inc. (NASDAQ: AREX), down 8 percent.

Top 10 Value Stocks To Invest In 2018: (PIONF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    International Lithium (ILC) is a small lithium explorer/project generator with four joint venture lithium projects, and one fully-owned lithium project:

    Mariana lithium brine in Argentina (20% ILC: 80% GFL). ILC can increase to 30% via a 10% back-in right. Jiangxi Ganfeng Lithium (GFL) is committed to US$10m in expenditures at Mariana. This is their flagship project. Avalonia lithium pegmatite in Ireland (45% ILC: 55% GFL). GFL has the option to acquire an additional 24% after spending US$10m, or producing a Feasibility Study [FS]. Mavis Lake and Raleigh lithium pegmatite in Ontario Canada (49% ILC: 51% Pioneer Resources Limited (OTC:PIONF)). 100% of the Forgan Lake pegmatite project in Canada.

    Note that Avalon, Mavis Lake, Raleigh, and Forgan Lake also have rare earths. Jiangxi Ganfeng Lithium (SHE:002460) has an 18.1% stake in ILC in addition to the above joint venture partnerships.

Top 10 Value Stocks To Invest In 2018: Nu Skin Enterprises Inc.(NUS)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Citigroup’s Beth Kite calls Nu Skin Enterprises’ (NUS) earnings and guidance “awfully disappointing.” She explains why:

    “Frustrating” Describes 4Q15 & 2016 Guidance:Nu Skin (i) reported 4Q15 EPS of $0.62, 11 cents below consensus and us, and (ii) lowered 2016 EPS guidance, from $3.25-$3.40 to $2.40-$2.60.Nu Skin had three LTO’s in 4Q152 succeeded and 1 failed. The failure had far less to do with the product than with the sales strategy…

    Is Guidance Too Conservative or Is It Really This Bad? We get that Me failed to sell well in South Korea with the 12-month cartridge commitment. But given the strength in reps globally, the strength of Youth from its two LTOs in 2H15, and good results from Me when sold in Japan without the 12-month commitment, we wonder if guidance is aggressive to the downside. Indeed, the word “conservative” was said a lot by mgmt on the brief earnings call when describing guidance revisions.

    Maintaining Buy: While we now have less confidence in mgmt, from an external perspective, to forecast its results accurately, and from an internal perspective, to course correct quicklyi.e., why didn’t they drop the 12-month plan for Me in South Korea when it so obviously wasn’t workingwe are still confident in Youth & Me. The rep growth in South Asia/Pacific from Youth in 3Q led to better 4Q sales than we’d expected, Youth’s Americas LTO in 4Q drove lc sales up 26% YoY, and Me not only sold through in Japan in 4Q but also drove reps higher. We imagine that investors may have little patience or confidence in Nu Skin for a while, understandably. But the bar seems set fairly low now, so we are cautiously optimistic that Nu Skin can dig itself out of this hole as we go through 2016 and Me & Youth roll out more fully.

    Shares of Nu Skin have tumbled 13% to $27.31 at 2:11 p.m. today.

  • [By Roberto Pedone]

    Nu Skin Enterprises (NUS) is a direct selling company, which develops and distributes personal care products and nutritional supplements that are sold under the Nu Skin and Pharmanex brands. This stock closed up 5.4% at $92.96 in Monday’s trading session.

    Monday’s Volume: 2 million

    Three-Month Average Volume: 900,802

    Volume % Change: 85%

    From a technical perspective, NUS ripped higher here right above some near-term support at $85 with heavy upside volume. This move pushed shares of NUS into breakout and new 52-week-high territory, since the stock took out some near-term overhead resistance levels at $88.20 to $89.69. This move also pushed shares of NUS above the upper-end of its recent range that saw the stock trend between $82 to just above $89.

    Traders should now look for long-biased trades in NUS as long as it’s trending above support at $85 and then once it sustains a move or close above Monday’s high of $93.33 with volume that this near or above 900,802 shares. If we get that move soon, then NUS will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $100 to $105.

  • [By Craig Jones]

    Nu Skin Enterprises, Inc. (NYSE: NUS) is trading sharply higher on Friday, but options traders are buying puts in the name, said Jon Najarian. Traders were buying the June 50 puts and they paid around 6 percent for them, so they don't see much upside in Nu Skin Enterprises, explained Najarian. He followed the trade and he is planning to hold the position for a month.

  • [By Scott Rubin]

    Stock gainers included Mercadolibre Inc (NASDAQ: MELI), up almost 14 percent, and Nu Skin Enterprises, Inc. (NYSE: NUS), which added 12 percent. The positive gains in both stocks were due to strong earnings reports. Shares of Liberty Interactive Group (NASDAQ: QVCA) plunged almost 22 percent on Friday due to disappointing sales growth in its fiscal second quarter. Pharmaceutical giant Bristol-Myers Squibb Co (NYSE: BMY) lost 16 percent after a disappointing study involving its Opdivo drug.

  • [By ]

    Nu Skin Enterprises (NYSE: NUS) is benefiting from two key trends: its strong presence in Asia where it books 79% of its revenue and leading brand awareness with millennials. The company has increased its dividend every year since 2001, now paying a 2% yield, and maintains a share repurchase program that returns excess cash to shareholders.

Top 10 Value Stocks To Invest In 2018: MGM Resorts International(MGM)

Advisors’ Opinion:

  • [By Ben Levisohn]

    MGM Resorts International (MGM) always had two things going for it: It’s large Las Vegas footprint to counter the weakness in Macau, and it’s real-estate, which it spun off into MGM Growth Properties (MGP). But when MGM reported weaker than expected earnings this morning, it wasn’t a good sign that Las Vegas was disappointing. Wells Fargo’sCameron McKnight explains:

    Getty Images

    Q4 Las Vegas EBITDA of $365mm was 10% ($40MM) below the Street. Las Vegas 4Q RevPAR growth of +3% was in-line with guidance, but below our expectations and industry data. For the 1Q17, MGM provided RevPAR guidance of 7%, a point or two below our expectations. We estimate revenue growth per visitor was +1.5% yr/yr. RevPOR (other revenue per occupied room) growth was +1.5%. We estimate expenses were +1% yr/yr. We expect the stock to be trade down on this morning’s release. While forward guidance was tepid, MGM missed Las Vegas expectations.

    Shares of MGM Resorts International have tumbled 7.3% to $27.45 at 11:37 a.m. today, while MGM Resorts Properties has declined 0.3% to $25.58.

  • [By Ben Levisohn]

    With companies like Under Armour (UAA), MGM Resorts International (MGM), andUnited Parcel Service (UPS) reporting tomorrow, we thought we’d get a jump start on the stocks moving after today’s close:

  • [By Wayne Duggan]

    Bernstein maintains Outperform ratings on Melco Crown Entertainment Ltd (ADR) (NASDAQ: MPEL) and the China units of Wynn Resorts, Limited (NASDAQ: WYNN) and MGM Resorts International (NYSE: MGM).

  • [By Travis Hoium]

    MGM Resorts (NYSE:MGM) has also taken a fairly aggressive approach to Japan, releasing renderings of what its casino might look like in Osaka. And given the company’s renewed financial health, it’s possible it would be a good bet to win a gaming concession.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Avon Products, Inc. (NYSE: AVP) to report quarterly earnings at $0.10 per share on revenue of $1.62 billion before the opening bell. Avon Products shares rose 2.39 percent to $6.00 in after-hours trading.
    Analysts expect MGM Resorts International (NYSE: MGM) to report quarterly earnings at $0.20 per share on revenue of $2.44 billion before the opening bell. MGM shares rose 1.01 percent to $29.90 in after-hours trading.
    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected results for its second quarter and raised its quarterly dividend to $0.29 per share. Cisco shares rose 2.13 percent to $33.52 in the after-hours trading session.
    Before the markets open, Dean Foods Co (NYSE: DF) is projected to report its quarterly earnings at $0.41 per share on revenue of $2.01 billion. Dean Foods shares rose 0.49 percent to $20.55 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) posted weaker-than-expected results for its fourth quarter on Wednesday. Tripadvisor shares dropped 5.60 percent to $49.75 in the after-hours trading session.
    Analysts are expecting Waste Management, Inc. (NYSE: WM) to have earned $0.77 per share on revenue of $3.42 billion in the latest quarter. Waste Management will release earnings before the markets open. Waste Management shares rose 2.27 percent to $72.97 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Jon C. Ogg]

    MGM Resorts International (NYSE: MGM) is also a top pick for the first quarter, and Merrill Lynch’s price objective of $33.00 was versus a recent price of $28.50. The consensus analyst target price is a tad higher at $33.86.

Top 10 Value Stocks To Invest In 2018: HSBC Holdings plc(HSBC)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Up first on our list of financial sector breakout trades is $156 billion global bank HSBC Holdings plc (HSBC) . Don’t get fooled by the headline numbers in HSBC this year – shares may be hovering around breakeven year-to-date, but they’re up more than 35% from their April lows. And after tracking sideways for the last couple of months, HSBC is back in breakout mode this week.

  • [By Elizabeth Balboa]

    Here are the top 10 financial bodies investing in lobbying in 2017:

    American Bankers Association: $5.6 million
    Securities Industry & Financial Market Association: $3.5 million
    Financial Services Roundtable: $3.0 million
    Independent Community Bankers of America: $2.7 million
    Association of International CPAs: $2.6 million
    Citigroup Inc (NYSE: C): $2.5 million
    Investment Company Institute: $2.4 million
    S&P Global Inc (NYSE: SPGI): $2.4 million
    Credit Union National Association: $2.4 million
    HSBC Holdings plc (ADR) (NYSE: HSBC): $2.4 million

    Dozens of others spent more than $1 million, including Ally Financial Inc (NYSE: ALLY), Visa Inc (NYSE: V) and Navient Corp (NASDAQ: NAVI).

  • [By Money Morning News Team]

    And the Aramco IPO is making progress. On Feb. 7, the Saudi Arabian oil company hired Moelis & Co. (NYSE:MC) as its IPO advisor. Then on Feb. 21, the company hired the lead underwriters for the IPO. Wall Street stalwarts JPMorgan Chase & Co. (NYSE: JPM), Morgan Stanley (NYSE: MS), and HSBC Holdings Plc. (NYSE ADR: HSBC) won the lucrative underwriting contracts.

Top 10 Value Stocks To Invest In 2018: Cognizant Technology Solutions Corporation(CTSH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Cognizant Technology Solutions Corp (NASDAQ: CTSH) is estimated to report its quarterly earnings at $0.79 per share on revenue of $3.23 billion.

    CIGNA Corporation (NYSE: CI) is projected to report its quarterly earnings at $2.15 per share on revenue of $10.00 billion.

  • [By Shanthi Rexaline]

    The industry — valued at over $150 billion and comprising companies such as Wipro Limited (ADR) (NYSE: WIT), Cognizant Technology Solutions Corp (NASDAQ: CTSH), Infosys Ltd ADR (NYSE: INFY) and Tata Consultancy Services — has thus far been competing effectively on certain unique selling propositions such as low-cost technology skills and high quality manpower.

  • [By WWW.THESTREET.COM]

    And Elliott could be pressuring two public companies to combine. One company that analysts contend could be interested in buying Advisory Board’s healthcare business, which represents about 80% of the company, is Cognizant Technology Solutions (CTSH) . The Teaneck, N.J.-based business has been under pressure in recent months by Elliott Management to take on more leverage to help fund research and M&A. 

  • [By Keith Speights]

    That’s a pretty good definition of leadership, but it’s not an easy one to accomplish. However, the CEOs of Celgene (NASDAQ:CELG), Cognizant Technology Solutions (NASDAQ:CTSH), General Electric (NYSE:GE), MasterCard (NYSE:MA), and Texas Instruments (NASDAQ:TXN) have been able to achieve this translation very well.

Top 10 Value Stocks To Invest In 2018: Surgical Care Affiliates, Inc.(SCAI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Surgical Care Affiliates Inc (NASDAQ: SCAI) shares were also up, gaining 16 percent to $56.55 after UnitedHealth Group Inc. (NYSE: UNH) disclosed that its unit agreed to acquire Surgical Care Affiliates for around $2.3 billion.

Top 10 Value Stocks To Invest In 2018: Westar Energy, Inc.(WR)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Yet even on a good day, some stocks couldn’t keep up, and Ocwen Financial (NYSE:OCN), Westar Energy (NYSE:WR), and United Rentals (NYSE:URI) were among the worst performers. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Lisa Levin]

    On Thursday, utilities shares rose by 0.02 percent. Top gainers in the sector included Westar Energy Inc (NYSE: WR), Westar Energy Inc (NYSE: AT), and NRG Energy Inc (NYSE: NRG).

  • [By Jayson Derrick]

    According to a report by Bloomberg, Westar Energy Inc (NYSE: WR) is a potential takeover target from rival Ameren Corp (NYSE: AEE) and a consortium of investors, including Toronto-based Borealis Infrastructure Management and the Canada Pension Plan Investment Board.

  • [By Lisa Levin]

    In trading on Thursday, utilities shares fell by 0.34 percent. Meanwhile, top losers in the sector included Westar Energy Inc (NYSE: WR), down 7 percent, and Companhia de Saneamento Basico (ADR) (NYSE: SBS), down 5 percent.

Top 10 Value Stocks To Invest In 2018: Sanofi(SNY)

Advisors’ Opinion:

  • [By Stephen Mack]

    JNJ has recently made substantial investments in its pharmaceuticals pipeline. Most notably, in January the company beat Sanofi SA (NYSE: SNY) to buy a stake in Swiss drug company Actelion. The pairing is a perfect match, as it bulks up Johnson & Johnson’s pipeline, and gives Actelion the reach of a global powerhouse.

  • [By Ben Levisohn]

    Hopes were high for MannKind (MNKD) when its inhaled insulin Afrezza was approved by the FDA more than two years ago. At the time, Barron’s warned that it was time to dump MannKind’s shares, something that now seems prescient, as its shares have since tumbled 95%. No wonder, as the news since then has been far from good. MannKind found a partner in Sanofi (SNY), only to get dumped in early 2016, and has since been forced to sell property to raise cash. And now MannKind could be on the verge of being delisted from the Nasdaq due to its sub $1 stock price. What now? Piper Jaffray’sJoshua Schimmer and team see a reverse stock split in MannKind’s future:

  • [By Diane Alter]

    Basically, the Phab 2 Pro allows users more ways to explore no matter where they are or go. Lenovo shares were 1.82% at $12.89 in today’s (Thursday) morning session.

    CES Companies to Watch, No. 4: Sony (NYSE: SNY)

    Sony Corp ADR (NYSE: SNE) ventured into the OLED television space with its new A1E series unveiling. The new TVs come in 55, 65, and 77 inch sizes, run on Android, and work with Google Home. Sony said that moving to OLED allows it to offer a TV with “unprecedented black levels, rich and lifelike color, dynamic contrast, blur-less image, and a wide viewing angle.”

  • [By ]

    If thats not enough excitement for you, French drug maker Sanofi SA (NYSE:SNY) announced it’s buying Bioverativ (NASDAQ:BIVV) for $11.6 billion. The deal pushed BIVV shares up more than 60% by the closing bell.